Fortis Advisors’s Novo Nordisk NVO Stock Holding History

Fortis Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-276	Closed	-$9K	–	170
2020 Q2	$9K	Hold	276	–	–	0.01%	147
2020 Q1	$8K	Hold	276	–	–	0.01%	273
2019 Q4	$8K	Hold	276	–	–	﹤0.01%	274
2019 Q3	$7K	Hold	276	–	–	﹤0.01%	279
2019 Q2	$7K	Hold	276	–	–	﹤0.01%	311
2019 Q1	$7K	Hold	276	–	–	﹤0.01%	298
2018 Q4	$6K	Hold	276	–	–	﹤0.01%	284
2018 Q3	$7K	Sell	276 -144	-34%	-$3.51K	﹤0.01%	279
2018 Q2	$10K	Hold	420	–	–	0.01%	268
2018 Q1	$10K	Buy	420 +276	+192%	+$7.25K	0.01%	244
2017 Q4	$4K	Hold	144	–	–	﹤0.01%	269
2017 Q3	$3K	Buy	+144	New	+$3.25K	﹤0.01%	270

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Fortis Advisors's NVO Position: Q3 2020 in Review

Fortis Advisors sold out of Novo Nordisk (NVO) in Q3 2020, closing a stake of 276 shares — an estimated $9K sold.

Fortis Advisors first reported a position in NVO in Q3 2017 and held it in 12 quarters. The position peaked at $10K in Q2 2018. 659 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

Fortis Advisors reported no remaining Novo Nordisk position as of Q3 2020 after selling out during the quarter.
Fortis Advisors sold 276 Novo Nordisk shares in Q3 2020, an estimated $9K.
Fortis Advisors first reported a position in Novo Nordisk in Q3 2017 and held it in 12 quarters.
Fortis Advisors's Novo Nordisk position peaked at $10K in Q2 2018.
659 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Fortis Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.